XML 14 R4.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements of Income and Comprehensive Income (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended
Mar. 31, 2019
Apr. 01, 2018
Revenues [1] $ 18,882 $ 23,069
Cost of Products Sold 13,798 15,787
Gross Profit 5,084 7,282
Operating Expenses:    
Research and Development 1,036 1,101
Selling, General and Administrative 3,500 3,825
Total Operating Expenses 4,536 4,926
Operating Income 548 2,356
Other Expenses:    
Interest and Financing Expense (5) (33)
Miscellaneous (53) (100)
Total Other Expenses (58) (133)
Income Before Income Tax Provision 490 2,223
Income Tax Provision (41) (55)
Net Income 449 2,168
Net Income Attributable to Non-Controlling Interest (24) (17)
Net Income Attributable to Ultralife Corporation 425 2,151
Other Comprehensive Income:    
Foreign Currency Translation Adjustments 435 752
Comprehensive Income Attributable to Ultralife Corporation $ 860 $ 2,903
Net Income Per Share Attributable to Ultralife Common Shareholders – Basic (in dollars per share) $ 0.03 $ 0.14
Net Income Per Share Attributable to Ultralife Common Shareholders – Diluted (in dollars per share) $ 0.03 $ 0.13
Weighted Average Shares Outstanding – Basic (in shares) 15,740 15,704
Potential Common Shares (in shares) 485 498
Weighted Average Shares Outstanding – Diluted (in shares) 16,225 16,202
[1] Sales classified to U.S. include shipments to U.S.-based prime contractors which in some cases may serve non-U.S. projects